Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants (DIVI): study protocol for a randomized, blinded phase II trial
Authors
John Feltner
Jill D. Irvine
Kendell German (ORCID: https://orcid.org/0000-0002-0046-621X)
Dennis E. Mayock (ORCID: https://orcid.org/0000-0002-6190-4842)
E. Lagerquist
Bryan A. Comstock
Sandra E. Juul
Patrick J. Heagerty
Institutions
Seattle Pacific University (US)
German Institute of Development and Sustainability (DE)
National Institute of Child Health and Human Development
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants (DIVI): study protocol for a randomized, blinded phase II trial
John Feltner, Jill D. Irvine, Kendell German, Dennis E. Mayock et al.
Journal
Trials
Topics
Neonatal and fetal brain pathology
article
Darbepoetin plus slow-release IntraVenous Iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants (DIVI): study protocol for a randomized, blinded phase II trial
John Feltner, Jill D. Irvine, Kendell German, Dennis E. Mayock, E. Lagerquist, Bryan A. Comstock, Sandra E. Juul, Patrick J. Heagerty
article en
Abstract
No abstract available for this paper.
Publication Tag
TrialsVol. 26(1)
Institutions
Seattle Pacific University (US), German Institute of Development and Sustainability (DE), University of Washington (US), National Disability Institute (US)
Funders
National Institute of Child Health and Human Development, Eunice Kennedy Shriver National Institute of Child Health and Human Development